Home/Filings/4/0001415889-23-003856
4//SEC Filing

Sorg Elaine K. 4

Accession 0001415889-23-003856

CIK 0001551152other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:07 PM ET

Size

9.9 KB

Accession

0001415889-23-003856

Insider Transaction Report

Form 4
Period: 2023-02-28
Sorg Elaine K.
Sr. V.P., U.S. Commercial Ops.
Transactions
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2023-03-01$93.50/sh+15,003$1,402,78157,832 total
  • Exercise/Conversion

    Option (Right to Buy)

    2023-03-01$93.50/sh15,003$1,402,7810 total
    Exercise: $93.50From: 2020-02-20Exp: 2030-02-19Common Stock (15,003 underlying)
  • Tax Payment

    Common Stock, $0.01 par value

    2023-02-28$154.28/sh19,850$3,062,45842,829 total
  • Sale

    Common Stock, $0.01 par value

    2023-03-01$155.00/sh15,003$2,325,46542,829 total
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001832571

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 5:07 PM ET
Size
9.9 KB